Omalizumab et immunothérapie allergénique : cas clinique et revue de la littérature
- 3 November 2018
- journal article
- review article
- Published by Elsevier BV in Revue des Maladies Respiratoires
- Vol. 36 (2), 191-196
- https://doi.org/10.1016/j.rmr.2018.03.006
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Advances in paediatrics in 2016: current practices and challenges in allergy, autoimmune diseases, cardiology, endocrinology, gastroenterology, infectious diseases, neonatology, nephrology, neurology, nutrition, pulmonologyItalian Journal of Pediatrics, 2017
- Omalizumab and allergen immunotherapy in a patient with asthma and inhaled corticosteroid–induced adrenal suppressionAnnals of Allergy, Asthma & Immunology, 2016
- The relationship between allergen immunotherapy and omalizumab for treating asthmaExpert Review of Respiratory Medicine, 2015
- Letter to the Editor Children with severe asthma can start allergen immunotherapy after controlling asthma with omalizumab: a case series from PolandVideosurgery and Other Miniinvasive Techniques, 2015
- Use of omalizumab to improve desensitization safety in allergen immunotherapyJournal of Allergy and Clinical Immunology, 2014
- Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapyPediatric Allergy and Immunology, 2013
- Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthmaJournal of Allergy and Clinical Immunology, 2010
- Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen bindingJournal of Allergy and Clinical Immunology, 2007
- Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitisJournal of Allergy and Clinical Immunology, 2006
- Traitement par anticorps anti-IgE de l’asthme allergique difficile à contrôlerRevue des Maladies Respiratoires, 2005